Contents

Current Pharmaceutical Design, Volume 12 - Number 32

Editorial [Hot Topic: Toll-Like Receptors and Innate Immunity: Potential Drug Targets for Treatment of Infectious, Inflammatory, and Autoimmune Diseases (Executive Editor: Emilio Jirillo)]

, 12(32): 4089 - 4090

Emilio Jirillo


DOI: 10.2174/138161206778743475




Evolution of a “Conserved” Amino Acid Sequence: a Model Study of an In Silico Investigation of the Phylogenesis of Some Immune Receptors

, 12(32): 4091 - 4121

M. A. Panaro, A. Acquafredda, M. Sisto, S. Lisi, M. Saccia and V. Mitolo


DOI: 10.2174/138161206778743439




TLR Signaling Pathways: Opportunities for Activation and Blockade in Pursuit of Therapy

, 12(32): 4123 - 4134

K. Hoebe, Z. Jiang, P. Georgel, K. Tabeta, E. Janssen, X. Du and B. Beutler


DOI: 10.2174/138161206778743466




‘Toll’ Gates for Future Immunotherapy

, 12(32): 4135 - 4142

Ken J. Ishii, Satoshi Uematsu and Shizuo Akira


DOI: 10.2174/138161206778743484




Negative Regulators of Toll-like Receptor 4-Mediated Macrophage Inflammatory Response

, 12(32): 4143 - 4153

Jonathan P. Butchar, Kishore V.L. Parsa, Clay B. Marsh and Susheela Tridandapani


DOI: 10.2174/138161206778743574




Molecular Basis for Invertebrate Innate Immune Recognition of (1→3)-β- D-Glucan as A Pathogen-Associated Molecular Pattern

, 12(32): 4155 - 4161

T. Muta


DOI: 10.2174/138161206778743529




Enhancement of TLR-Mediated Innate Immune Responses by Peptidoglycans through NOD Signaling

, 12(32): 4163 - 4172

H. Takada and A. Uehara


DOI: 10.2174/138161206778743510




Toll-Like Receptors in Human Infectious Diseases

, 12(32): 4173 - 4184

S. de la Barrera, M. Aleman and M. del C. Sasiain


DOI: 10.2174/138161206778743493




TLR2 and TLR4 Expression During Bacterial Infections

, 12(32): 4185 - 4193

E. Lorenz


DOI: 10.2174/138161206778743547




Recognition of Fungal Pathogens by Toll-Like Receptors

, 12(32): 4195 - 4201

Mihai G. Netea, Gerben Ferwerda, Chantal A.A. van der Graaf, Jos W. M. Van der Meer and Bart Jan Kullberg


DOI: 10.2174/138161206778743538




Innate Immunity in the Mucosal Immune System

, 12(32): 4203 - 4213

Tomonori Nochi and Hiroshi Kiyono


DOI: 10.2174/138161206778743457




Therapeutic Targeting of Toll-Like Receptors in Gastrointestinal Inflammation

, 12(32): 4215 - 4228

Shunji Ishihara, Mohammad A.K. Rumi, Cesar-F. Ortega-Cava, Hideaki Kazumori, Yasunori Kadowaki, Norihisa Ishimura and Yoshikazu Kinoshita


DOI: 10.2174/138161206778743448




Endotoxin, TLR4 Signaling and Vascular Inflammation: Potential Therapeutic Targets in Cardiovascular Disease

, 12(32): 4229 - 4245

Lynn L. Stoll, Gerene M. Denning and Neal L. Weintraub


DOI: 10.2174/138161206778743501




Toll-Like Receptor Signaling Mechanisms Involved in Dendritic Cell Activation: Potential Therapeutic Control of T Cell Polarization

, 12(32): 4247 - 4254

Luigi Amati, Maria Pepe, Maria Elena Passeri, Maria Letizia Mastronardi, Emilio Jirillo and Vito Covelli


DOI: 10.2174/138161206778743583




Toll-Like Receptor-Positive Cells and Recognition of Pathogens: How Human Myeloid Dendritic Cells Respond to In Vitro Infection with Leishmania infantum

, 12(32): 4255 - 4262

Maria Pepe, Maria Altamura, Rosa Spinelli, Rosa Calvello, Matteo Saccia, Pasqua Cavallo, Vito Covelli, Emilio Jirillo and Olga Brandonisio


DOI: 10.2174/138161206778743556




In Vitro Infection of Human Monocyte-Derived Dendritic Cells with Candida albicans: Receptorial Involvement and Therapeutic Implications

, 12(32): 4263 - 4269

Maria Pepe, Emilio Jirillo and Vito Covelli


DOI: 10.2174/138161206778743592




Immunomodulating Effects of Flavonoids on Acute and Chronic Inflammatory Responses Caused by Tumor Necrosis Factor α

, 12(32): 4271 - 4279

Yoshio Kumazawa, Kiichiro Kawaguchi and Hiroaki Takimoto


DOI: 10.2174/138161206778743565




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science